Literature DB >> 44887

Further observations on a low-molecular-weight natriuretic substance in the urine of normal man.

E M Clarkson, S M Raw, H E De Wardener.   

Abstract

Large quantities of the low-molecular-weight natriuretic material (F4), which appears after the salts when fractionated on G-25 Sephadex column, were obtained from the urine of normal man on a normal diet. The natriuretic substance in F4 was (1) untrafiltrable through a membrane with a claimed molecular-weight cut-off of 500 daltons (Amicon UMO5); (2) soluble in more polar organic solvents; (3) totally soluble in 95% acetone when specific activity was doubled; (4) relatively resistant to heating at 100 degrees C for 1 hour at a pH of 10, and to heating at 110 degrees C in 6 N hydrochloric acid for up to 90 hours under anaerobic conditions, and treatment with nitrous acid; it was less resistant to these procedures when extracted into 95% acetone; (5) not destroyed by trypsin, chymotrypsin, pronase, pepsin, leucine aminopeptidase, and subtilysin, nor was it destroyed by pepsin, leucine aminopeptidase, subtilysin, carboxypeptidase A and B, and aminopeptidase M, or by monoamine oxidase, aryl sulphatase, and beta-glucuronidase when extracted into 95% acetone. The natriuretic substance in the 95% acetone-soluble F4 was totally destroyed by incubation with prolidase. The least amount of 95% acetone-soluble F4 required to produce a significant natriuresis in the bioassay rat was that derived from a 7-min sample of urine. The maximal response was obtained from a 30-min sample of urine. Continuous i.v. infusion of the 95% acetone-soluble F4 for 40 min produced a sustained natriuresis, whereas a greater amount injected as a bolus produced an effect which was not sustained beyond 20 min.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 44887     DOI: 10.1038/ki.1979.187

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Identification, purification and partial characterization of low molecular weight protein inhibitor of Na⁺/K⁺-ATPase from pulmonary artery smooth muscle cells.

Authors:  Sayed Modinur Rahaman; Kuntal Dey; Partha Das; Soumitra Roy; Tapati Chakraborti; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2014-05-22       Impact factor: 3.396

2.  Purification from human plasma of endogenous sodium transport inhibitor(s).

Authors:  J F Cloix; G Dagher; M Crabos; M G Pernollet; P Meyer
Journal:  Experientia       Date:  1984-12-15

3.  New evidence linking salt and hypertension.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-20

4.  Relationship of specific granules to the natriuretic and diuretic activity of rat atria.

Authors:  R Garcia; M Cantin; G Thibault; H Ong; J Genest
Journal:  Experientia       Date:  1982-09-15

5.  Natriuretic factor exerts a ouabain-like activity in the rat colon in vitro.

Authors:  B Martin; H Favre
Journal:  Pflugers Arch       Date:  1984-03       Impact factor: 3.657

6.  Measurement of digitalis-like compound in plasma: application in studies of essential hypertension.

Authors:  M A Devynck; M G Pernollet; J B Rosenfeld; P Meyer
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-03

7.  Sodium excess or potassium lack as a cause of hypertension: a discussion paper.

Authors:  C J Bulpitt
Journal:  J R Soc Med       Date:  1981-12       Impact factor: 18.000

8.  Erythrocyte sodium transport in dialyzed uremic patients.

Authors:  Y S Yoon; S Y Kim; W S Koo; E J Choi; Y S Chang; B K Bang; H R Moon
Journal:  Korean J Intern Med       Date:  1989-01       Impact factor: 2.884

Review 9.  Natriuretic hormones, endogenous ouabain, and related sodium transport inhibitors.

Authors:  John M Hamlyn
Journal:  Front Endocrinol (Lausanne)       Date:  2014-12-03       Impact factor: 5.555

10.  Erythrocyte Na(+)-K+ ATPase activity in the genesis of reducing renal mass in hypertensive rats.

Authors:  Y S Yoon; B K Bang; B S Min; H J Kim
Journal:  Korean J Intern Med       Date:  1986-07       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.